142
Views
37
CrossRef citations to date
0
Altmetric
Review

Interest in paromomycin for the treatment of visceral leishmaniasis (kala-azar)

Pages 323-328 | Published online: 22 Jun 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Farnaz Zahedifard & Sima Rafati. (2018) Prospects for antimicrobial peptide-based immunotherapy approaches in Leishmania control. Expert Review of Anti-infective Therapy 16:6, pages 461-469.
Read now

Articles from other publishers (36)

Ignace C. Roseboom, Hilde Rosing, Jos H. Beijnen & Thomas P. C. Dorlo. (2022) Bioanalytical methods for pharmacokinetic studies of antileishmanial drugs. Biomedical Chromatography 37:7.
Crossref
Ganesh Yadagiri, Aakriti Singh, Kanika Arora & Shyam Lal Mudavath. (2023) Immunotherapy and immunochemotherapy in combating visceral leishmaniasis. Frontiers in Medicine 10.
Crossref
Sina Bahraminejad, Abbas Pardakhty, Iraj Sharifi, Alireza Keyhani, Ehsan Salarkia & Mehdi Ranjbar. (2023) Synthesis and physicochemical characterization of Zn–Al layered double hydroxides (LDHs) as a delivery system for amphotericin B: In vitro and in silico antileishmanial study. Heliyon 9:4, pages e15308.
Crossref
Shabi Parvez, Archana Karole, Yirivinti Hayagreeva Dinakar & Shyam Lal Mudavath. (2022) Nanoformulation mediated silencing of P-gp efflux protein for the efficient oral delivery of anti-leishmanial drugs. Journal of Drug Delivery Science and Technology 78, pages 103959.
Crossref
Bassel Awada, Maguy Hamie, Rana El Hajj, Ghada Derbaj, Rania Najm, Perla Makhoul, Dima Hajj Ali, Antoine G. Abou Fayad & Hiba El Hajj. (2022) HAS 1: A natural product from soil-isolated Streptomyces species with potent activity against cutaneous leishmaniasis caused by Leishmania tropica. Frontiers in Pharmacology 13.
Crossref
Sabya Sachi Das, Amit Kumar Dubey, Priya Ranjan Prasad Verma, Shubhankar Kumar Singh & Sandeep Kumar Singh. (2022) Therapeutic Potential of Quercetin-Loaded Nanoemulsion against Experimental Visceral Leishmaniasis: In Vitro / Ex Vivo Studies and Mechanistic Insights . Molecular Pharmaceutics 19:9, pages 3367-3384.
Crossref
R. Sivayogana, Aishwarya Krishnakumar, S. Kumaravel, Rajesh Rajagopal & P. Ravikanth. 2022. Leishmaniasis - General Aspects of a Stigmatized Disease. Leishmaniasis - General Aspects of a Stigmatized Disease.
Wessal Hanout & Nir Qvit. 2022. Peptide and Peptidomimetic Therapeutics. Peptide and Peptidomimetic Therapeutics 371 415 .
Humzah Jamshaid, Fakhar ud Din & Gul Majid Khan. (2021) Nanotechnology based solutions for anti-leishmanial impediments: a detailed insight. Journal of Nanobiotechnology 19:1.
Crossref
Patrícia Fampa, Melissa Florencio, Raissa Couto Santana, Dayana Rosa, Deivid Costa Soares, Herbert Leonel de Matos Guedes, Anabela Cordeiro da Silva, Douglas Siqueira A. Chaves & Lucia H. Pinto-da-Silva. (2021) Anti-Leishmania Effects of Volatile Oils and Their Isolates. Revista Brasileira de Farmacognosia 31:5, pages 561-578.
Crossref
Patrick O. Sakyi, Richard K. Amewu, Robert N. O. A. Devine, Emahi Ismaila, Whelton A. Miller & Samuel K. Kwofie. (2021) The Search for Putative Hits in Combating Leishmaniasis: The Contributions of Natural Products Over the Last Decade. Natural Products and Bioprospecting 11:5, pages 489-544.
Crossref
Simone SC Oliveira, Carine S Ferreira, Marta H Branquinha, André LS Santos, Marco V Chaud, Sona Jain, Juliana C Cardoso, Anđelka B Kovačević, Eliana B Souto & Patrícia Severino. (2020) Overcoming multi‐resistant leishmania treatment by nanoencapsulation of potent antimicrobials. Journal of Chemical Technology & Biotechnology 96:8, pages 2123-2140.
Crossref
Sarah Hendrickx, João Luís Reis-Cunha, Sarah Forrester, Daniel C. Jeffares & Guy Caljon. (2021) Experimental Selection of Paromomycin Resistance in Leishmania donovani Amastigotes Induces Variable Genomic Polymorphisms. Microorganisms 9:8, pages 1546.
Crossref
Sarra Maamri, Khedidja Benarous & Mohamed Yousfi. (2021) Identification of 3-Methoxycarpachromene and Masticadienonic Acid as New Target Inhibitors against Trypanothione Reductase from Leishmania Infantum Using Molecular Docking and ADMET Prediction. Molecules 26:11, pages 3335.
Crossref
Vinita Gouri, Satish Chandra Pandey, Diksha Joshi, Veni Pande, Shobha Upreti & Mukesh Samant. 2021. Pathogenesis, Treatment and Prevention of Leishmaniasis. Pathogenesis, Treatment and Prevention of Leishmaniasis 141 159 .
Hafiz Muhammad Rizwan, Haider Abbas, Muhammad Sohail Sajid, Mahvish Maqbool, Malcolm K. Jones, Muhammad Irfan Ullah & Nabeel Ijaz. 2021. Biochemistry of Drug Resistance. Biochemistry of Drug Resistance 95 142 .
Igor A. Rodrigues, Andreza R. Garcia, Mariana M. Paz, Rogério G. D. Grilo Junior, Ana Claudia F. Amaral & Anderson S. Pinheiro. 2022. Antiprotozoal Drug Development and Delivery. Antiprotozoal Drug Development and Delivery 143 180 .
Dirlei Nico, Luciana Conde & Clarisa Beatriz Palatnik de Sousa. 2022. Antiprotozoal Drug Development and Delivery. Antiprotozoal Drug Development and Delivery 1 21 .
Awais Ahmad, N.M Mubarak, Khalida Naseem, Hina Tabassum, Muhammad Rizwan, Agnieszka Najda, M. Kashif, May Bin-Jumah, Afzal Hussain, Asma Shaheen, Mohamed M. Abdel-Daim, Shafaqat Ali & Shahid Hussain. (2020) Recent advancement and development of chitin and chitosan-based nanocomposite for drug delivery: Critical approach to clinical research. Arabian Journal of Chemistry 13:12, pages 8935-8964.
Crossref
Giuliana Muraca, Ignacio Rivero Berti, María L. Sbaraglini, Wagner J. Fávaro, Nelson Durán, Guillermo R. Castro & Alan Talevi. (2020) Trypanosomatid-Caused Conditions: State of the Art of Therapeutics and Potential Applications of Lipid-Based Nanocarriers. Frontiers in Chemistry 8.
Crossref
Jyoti Joshi, Chetna Bandral, Raj Kumar Manchanda, Anil Khurana, Debadatta Nayak & Sukhbir Kaur. (2020) The Effect of Iodium 30c on Experimental Visceral Leishmaniasis. Homeopathy 109:04, pages 213-223.
Crossref
Adane Adugna Ayalew. (2020) Chromatographic and spectroscopic determination of solvent-extracted Lantana camara leaf oil . Journal of International Medical Research 48:10, pages 030006052096234.
Crossref
Shweta Raj, Santanu Sasidharan, S. N. Balaji, Vikash Kumar Dubey & Prakash Saudagar. (2020) Review on natural products as an alternative to contemporary anti-leishmanial therapeutics. Journal of Proteins and Proteomics 11:2, pages 135-158.
Crossref
Kiran Saleem, Zainab Khursheed, Christophe Hano, Iram Anjum & Sumaira Anjum. (2019) Applications of Nanomaterials in Leishmaniasis: A Focus on Recent Advances and Challenges. Nanomaterials 9:12, pages 1749.
Crossref
Capela, Moreira & Lopes. (2019) An Overview of Drug Resistance in Protozoal Diseases. International Journal of Molecular Sciences 20:22, pages 5748.
Crossref
Vacas, Fernández-Rubio, Algarabel, Peña-Guerrero, Larrea, Rocha Formiga, García-Sosa & Nguewa. (2019) The Novel Serine/Threonine Protein Kinase LmjF.22.0810 from Leishmania major may be Involved in the Resistance to Drugs such as Paromomycin. Biomolecules 9:11, pages 723.
Crossref
Vineela Parvathaneni, Nishant S. Kulkarni, Aaron Muth & Vivek Gupta. (2019) Drug repurposing: a promising tool to accelerate the drug discovery process. Drug Discovery Today 24:10, pages 2076-2085.
Crossref
F. Esfandiari, M.H. Motazedian, Q. Asgari, M.H. Morowvat, M. Molaei & H. Heli. (2019) Paromomycin-loaded mannosylated chitosan nanoparticles: Synthesis, characterization and targeted drug delivery against leishmaniasis. Acta Tropica 197, pages 105072.
Crossref
F. Esfandiari, M.H. Motazedian, Q. Asgari, M.H. Morowvat, M. Molaei & H. Heli. (2019) Paromomycin-loaded mannosylated chitosan nanoparticles: Synthesis, characterization and targeted drug delivery against leishmaniasis. Acta Tropica 197, pages 105045.
Crossref
Farnaz Zahedifard, Hyeryon Lee, Joo Hwan No, Mona Salimi, Negar Seyed, Ahmad Asoodeh & Sima Rafati. (2019) Anti-leishmanial activity of Brevinin 2R and its Lauric acid conjugate type against L. major: In vitro mechanism of actions and in vivo treatment potentials. PLOS Neglected Tropical Diseases 13:2, pages e0007217.
Crossref
Viroj Wiwanitkit. 2019. Surface Modification of Nanoparticles for Targeted Drug Delivery. Surface Modification of Nanoparticles for Targeted Drug Delivery 167 181 .
Yongxian Fan, Yuele Lu, Xiaolong Chen, Babu Tekwani, Xing-Cong Li & Yinchu Shen. (2018) Anti-Leishmanial and Cytotoxic Activities of a Series of Maleimides: Synthesis, Biological Evaluation and Structure-Activity Relationship. Molecules 23:11, pages 2878.
Crossref
Maryam Akbari, Ahmad Oryan & Gholamreza Hatam. (2017) Application of nanotechnology in treatment of leishmaniasis: A Review. Acta Tropica 172, pages 86-90.
Crossref
Diana Cundell & Michael Piechoski. 2015. Antimicrobials. Antimicrobials 457 478 .
Maribel Navarro, Edgar Marchán, Alexis Maldonado, Zulay Simoni, Mariceny Velásquez, Leidi Herrera & Gonzalo Visbal. (2015) Anti-trypanosomatid activity of platinum–sterol hydrazone imidazoline complexes. Transition Metal Chemistry 40:7, pages 707-713.
Crossref
Somsri Wiwanitkit & Viroj Wiwanitkit. (2015) Emerging Leishmania siamensis in Southern Thailand: some facts and perspectives. Asian Pacific Journal of Tropical Disease 5:6, pages 502-504.
Crossref